Retraction Note: Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via

Y Yin1, Z-F Yang, X-H Li

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.

Insights

This study on long non-coding RNA LUCAT1 and cardiomyocyte injury has been retracted due to data reproducibility issues. The authors cannot confirm the reliability of the provided data.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • High glucose levels can induce cardiomyocyte injury, a critical factor in cardiovascular diseases.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cellular processes and disease.
  • LUCAT1 has been implicated in various cellular functions, but its role in high glucose-induced cardiac injury requires further investigation.

Purpose of the Study:

  • To investigate the role of long non-coding RNA LUCAT1 in high glucose-induced cardiomyocyte injury.
  • To explore whether knockdown of LUCAT1 could protect cardiomyocytes against high glucose damage.
  • To identify potential molecular targets, such as CYP11B2, involved in LUCAT1's effects.

Main Methods:

  • Cell culture models of high glucose-induced cardiomyocyte injury were established.
  • Lentivirus-mediated short hairpin RNA (shRNA) was used to knockdown LUCAT1 expression.
  • Cell viability, apoptosis, and oxidative stress markers were assessed.
  • The expression levels of CYP11B2 were measured.

Main Results:

  • High glucose exposure led to significant cardiomyocyte injury, evidenced by reduced cell viability and increased apoptosis.
  • Knockdown of LUCAT1 was shown to reverse these detrimental effects, improving cell survival and reducing apoptosis.
  • LUCAT1 knockdown also mitigated high glucose-induced oxidative stress.
  • The study suggested that LUCAT1 targets CYP11B2, influencing the observed protective effects.

Conclusions:

  • Long non-coding RNA LUCAT1 plays a detrimental role in high glucose-induced cardiomyocyte injury.
  • Knockdown of LUCAT1 demonstrates a protective effect against high glucose-induced cardiac damage.
  • CYP11B2 is identified as a potential molecular target through which LUCAT1 exerts its effects in cardiomyocytes.